- Research works
- 28 ▲ 4% vs 2013–17
- Citations
- 436 15.8 per fractional work
- Top-10% rate
- 16.2% record average 16.5%
- Open access
- 36% world 28%
Not ranked overall: 4D Pharma (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 4.8×. Every wedge is a field page.
- Neuroscience 4.8×
- Biochemistry, Genetics and Molecular Biology 3.2×
- Pharmacology, Toxicology and Pharmaceutics 3.1×
- Medicine 3.0×
- Economics, Econometrics and Finance 1.6×
- Decision Sciences 1.4×
- Immunology and Microbiology 1.1×
- Psychology 0.6×
- Materials Science 0.5×
- Computer Science 0.5×
- Health Professions 0.4×
- Agricultural and Biological Sciences 0.2×
- Engineering 0.1×
Which keywords describe research at 4D Pharma (United Kingdom)?
By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Gene Expression, Signal Transduction, Cancer, Metabolic Regulation, Genomics, Yeast and Immunotherapy.
- Tangeretin
- Nobiletin
- Keap1-Nrf2-ARE Pathway
- Neuroprotective
- Clinical Trials
- Bacterial Therapy
- Anti-inflammatory
- Tumor Targeting
- Genetic Variation
- Pattern Recognition Receptors
- Blood-Brain Barrier
- Short-Chain Fatty Acids
- Metabolism
- Chemotherapy
- Epidemiology
- Yeast
- Metabolic Regulation
- Oxidative Stress
- Gene Expression
- Inflammation
- Cancer
- Signal Transduction
- Genomics
- Immunotherapy
- Microbial Communities
- Gut Microbiota
- Metagenomic Analysis
- Tumor Microenvironment
- Neurovascular Unit
- Antioxidant
- Genome-Wide Association
- Alzheimer's Disease
- Arginine Deprivation
- Chaperones
- Marker-Assisted Selection
- Innate Antiviral Responses
- Mitochondrial Dysfunction
- Nrf2
- Toll-like Receptors
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 39 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 39 words, with their numbers
- Inflammation4▲ 5.5×9 topics
- Gene Expression3▲ 18×4 topics
- Cancer2▲ 6.5×7 topics
- Oxidative Stress2▲ 4.5×7 topics
- Signal Transduction2▲ 35×3 topics
- Metabolic Regulation2▲ 27×2 topics
- Genomics2▲ 21×1 topic
- Yeast2▲ 172×1 topic
- Immunotherapy2▲ 11×5 topics
- Epidemiology2▲ 1.53×10 topics
- Microbial Communities2▲ 17×2 topics
- Chemotherapy1▲ 7.0×5 topics
- Gut Microbiota1▲ 15×2 topics
- Metabolism1▲ 7.7×5 topics
- Metagenomic Analysis1▲ 87×1 topic
- Short-Chain Fatty Acids1▲ 87×1 topic
- Tumor Microenvironment1▲ 14×3 topics
- Blood-Brain Barrier1▲ 74×1 topic
- Neurovascular Unit1▲ 344×1 topic
- Pattern Recognition Receptors1▲ 33×2 topics
- Antioxidant1▲ 6.5×3 topics
- Genetic Variation1▲ 14×2 topics
- Genome-Wide Association1▲ 52×2 topics
- Tumor Targeting1▲ 32×2 topics
- Alzheimer's Disease1▲ 14×2 topics
- Anti-inflammatory1▲ 14×2 topics
- Arginine Deprivation1▲ 91×1 topic
- Bacterial Therapy1▲ 91×1 topic
- Chaperones1▲ 61×2 topics
- Clinical Trials1▲ 6.6×6 topics
- Marker-Assisted Selection1▲ 42×2 topics
- Neuroprotective1▲ 33×2 topics
- Innate Antiviral Responses1▲ 52×1 topic
- Keap1-Nrf2-ARE Pathway1▲ 145×1 topic
- Mitochondrial Dysfunction1▲ 9.9×3 topics
- Nobiletin1▲ 1091×1 topic
- Nrf21▲ 145×1 topic
- Tangeretin1▲ 1091×1 topic
- Toll-like Receptors1▲ 21×1 topic
Which research topics does 4D Pharma (United Kingdom) publish most on?
By volume in 2022–2025: Gut microbiota and health, Inhalation and Respiratory Drug Delivery, Asthma and respiratory diseases and Cancer Mechanisms and Therapy.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Gut microbiota and health Molecular Biology 0 works
- 2 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 0 works
- 3 Asthma and respiratory diseases Physiology 0 works
- 4 Cancer Mechanisms and Therapy Pathology and Forensic Medicine 0 works
- 5 Biomedical Ethics and Regulation Physiology 0 works
- 6 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
- 7 Ovarian cancer diagnosis and treatment Reproductive Medicine 0 works
- 8 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 9 Cancer Research and Treatments Biotechnology 0 works
- 10 Bladder and Urothelial Cancer Treatments Surgery 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has 4D Pharma (United Kingdom)'s research output changed?
Output in 2018–2022 was 4% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Leeds
- University of Leeds
- Leeds Beckett University
- Leeds General Infirmary
- St James's University Hospital
- Leeds Teaching Hospitals NHS Trust
- Feminist Archive North
- Hitachi (United Kingdom)
- National Centre for Atmospheric Science
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.